Optimizing the indication of vigabatrin in children with refractory epilepsy

Journal of Child Neurology

Volumn 12, Issue 4, 1997, Pages 253-259

  Lortie, Anne ^a   Chiron, Catherine ^a   Dumas, Caroline ^b   Mumford, John P ^c   Dulac, Olivier ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Marion Merrell Ltd UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIGABATRIN;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERANCE; FEMALE; HUMAN; INFANT; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD;

EID: 0030945646     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200407     Document Type: Article

References (46)

1. Mumford JP, Dam M: Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989;27:S101-S107.
2. Michelucci R, Tassinari CA: Response to vigabatrin in relation to seizure type. Br J Clin Pharmacol 1989;27:S119-S124.
3. Luna D, Dulac O, Pajot N, Beaumont D: Vigabatrin in the treatment of childhood epilepsies: A single-blind placebo-controlled study. Epilepsia 1989;30:430-137.
4. Dalla Bernardina B, Fontana E, Vigevano F, et al: Efficacy and tolerability of vigabatrin in children with refractory partial seizures: A single-blind dose-increasing study. Epilepsia 1995;36:687-691.
5. Chiron C, Dulac O, Beaumont D, et al: Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991; 6(Suppl 2):2S52-2S59.
6. Appleton RE, Monteil-Viesca F: Vigabatrin in infantile spasms: Why add-on? Lancet 1993;341:962.
7. Dulac O, Chiron C, Luna D, et al: Vigabatrin in childhood epilepsy. J Child Neurol 1991;6(Suppl 2):2S30-2S37.
8. Gibbs JM, Appleton RE, Rosenbloom L: Vigabatrin in intractable childhood epilepsy: A retrospective study. Pediatr Neurol 1992; 8:338-340.
9. Shields WD, Saalow E: Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983;33:1487-1489.
10. Snead OC, Hosey LC: Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916-921.
11. Lerman P: Seizures induced or aggravated by anticonvulsants. Epilepsia 1986;27:706-710.
12. Munn R, Farrell K: Open study of clobazam in refractory epilepsy. Pediatr Neurol 1993;9:465-469.
13. Kudriakova TB, Sirota LA, Rozova GI, Gorkov VA: Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites. Br J Clin Pharmacol 1992;33:611-615.
14. Roussounis SH, Rudolf N: Clonazepam in the treatment of children with intractable seizures. Dev Med Child Neurol 1977; 19:326-334.
15. Tassinari CA, Michelucci R, Ambrosetto G, Salvi F: Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol 1987;44:907-910.
16. Lortie A, Chiron C, Mumford J, Dulac O: The potential for increasing seizure frequency, seizure relapse, and appearance of new seizure types with vigabatrin. Neurology 1993;43(Suppl):S24-S27.
17. Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised clinical and electroencephalographical classification of epileptic seizures. Epilepsia 1981;22:489-501.
18. Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
19. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J: Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989;27(Suppl):S109-S112.
20. Uldall P, Alving J, Gram L, Beck S: Vigabatrin in pediatric epilepsy -an open study. J Child Neurol 1991;6(Suppl 2):2S38-2S44.
21. Herranz JL, Arteaga R, Fair IN, et al: Dose-response study of vigabatrin in children with refractory epilepsy. J Child Neurol 1991; 6(Suppl 2):2S45-2S51.
22. Vles BIS, Van der Heyden AM, Ghils A, Troost J: Vigabatrin in the treatment of infantile spasms. Neuropediatrics 1993;24:230-231.
23. Curatolo P: Vigabatrin for refractory partial seizures in children with tuberous sclerosis. Neuropediatrics 1994;25:55.
24. Vergnes M, Marescaux C: Pathophysiological mechanisms underlying genetic absence epilepsy in rats, in Malafosse A, Genton P, Hirsch E, et al (eds): Idiopathic Generalized Epilepsies: Clinical, Experimental and Genetic Aspects. London: John Libbey & Co, 1994, pp 151-168.
25. Gram L, Lyon BB, Dam M: Gamma-vinyl-GABA: A single-blind trial in patients with epilepsy. Acta Neurol Scand 1983;68:34-39.
26. Gram L, Klosterskov P, Dam M: Gamma-vinyl-GABA: A double-blind placebo-controlled trial in partial epilepsy. Ann Neurol 1985;17:262-266.
27. Livingston S (ed): Drug Therapy for Epilepsy. Springfield, IL, Charles C Thomas, 1966.
28. Vallarta JM, Bell DB, Reichert A: Progressive encephaly due to chronic hydantoin intoxication. Am J Dis Child 1974;128:27-34.
29. Callahan DJ, Noetzel MJ: Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992;42: 198-201.
30. Talwar D, Arora MS, Sher PK: EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994;35:1154-1159.
31. Gordon N: Treatment of epilepsy with α-ethyl-α-methylsuccinide (P.M. 671). Neurology 1961;11:266-268.
32. Friedel B, Lempp R: Grand-mal provokation bei der benandlung kindlicher petit-mal mit oxazolidinen oder succinimiden und ihre therapeutischen konzequenzen. Z Kinderheilk 1962;87:42-51.
33. Rosenberg HC, Tietz EI, Chiu TH: Tolerance to anticonvulsant effects of diazepam, clonazepam, and clobazam in amygdala-kindled rats. Epilepsia 1989;30:276-285.
34. Wildin JD, Pleuvry BJ: Tolerance to the anticonvulsant effects of clobazam in mice. Neuropharmacology 1992;31:129-135.
35. Neal MJ, Shah MA: Development of tolerance to the effects of vigabatrin (gamma-vinyl GABA) on GABA release from rat cerebral cortex, spinal cord, and retina. Br J Pharmacol 1990;100:324-328.
36. Rundfeldt C, Löscher W: Development of tolerance to the anticonvulsant effects of vigabatrin in amygdala-kindled rats. Eur J Pharmacol 1992;213:351-366.
37. Ben-Menachem E: Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans. Epilepsia 1989; 30(Suppl):S12-S14.
38. Changeux JP, Danchin A: Selective stabilization of developing synapses as a mechanism for the specification of neuronal networks. Nature 1976;264:705-712.
39. Dam M: Long-term evaluation of vigabatrin (gamma-vinyl GABA) in epilepsy. Epilepsia 1989;30(Suppl):S26-S30.
40. Remy C, Beaumont D: Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. Br J Clin Pharmacol 1989; 27(Suppl):S125-S129.
41. Tartara A, Manni R, Galimberti CA, et al: Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 1992;86:247-251.
42. Johsen SD, Tarby TJ, Sidell AD: Carbamazepine-induced seizures. Ann Neurol 1984;33:1487-1489.
43. de Bittencourt PRM, Mazer S, Marcourakis T, et al: Vigabatrin: Clinical evidence supporting rational polytherapy in the management of uncontrolled seizures. Epilepsia 1994;35:373-380.
44. Perucca E: Vigabatrin: The experience from the Italian multicentre trial, abstracted. Seizure 1992;(Suppl):S11/3.
45. Plouin P, Dulac O: Other types of seizures, in Dulac O, Chugani HT, Dalla Bernadina B (eds): Infantile Spasms and West Syndrome. London, WB Saunders, 1994, pp 52-62.
46. Dulac O, Chiron C, Robain O, et al: Infantile spasms: A pathophysiological hypothesis. Semin Pediatr Neurol 1994;1:83-89.